Hypertrophic cardiomyopathy (HCM) is a primary disease of cardiac muscle characterized by a thickening of the left ventricular wall and often predominantly affecting the interventricular septum. This ...
TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and 16482 Drug-Eluting Stents From Four Centers Receive the the latest news, research, and presentations from major ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
• Is the chordal-sparing mitral valve (MV) replacement (CCS-MVR) procedure effective in functional mitral regurgitation and degenerative mitral valve disease? • Does the CCS-MVR procedure improve left ...
Background A 48-year-old man with hypertrophic obstructive cardiomyopathy (HOCM) presented with palpitations, symptoms of medically refractory class II angina, and NYHA class II–III heart failure.
Future Cardiol. 2013;9(5):697-709. It is extremely important to detect the presence and severity of LVOT obstruction from physical examination, as well as 2D and Doppler echocardiography. The LVOT ...
Please provide your email address to receive an email when new articles are posted on . Mavacamten improved left ventricular hypertrophy, decreased measures of heart stiffness and restored normal ...
Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...
Broken heart syndrome, or Takotsubo cardiomyopathy (TCM), is a temporary and reversible disease presenting as an unexpected weakening of the left ventricular myocardium. It mainly occurs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback